News
12 Health Care Stocks Moving In Wednesday's After-Market Session
17 Apr 24
Movers
Fortress Biotech Q4 EPS $(0.53) Beats $(1.97) Estimate, Sales $19.95M Beat $14.89M Estimate
28 Mar 24
Earnings, Earnings Beats, News
Alliance Global Partners Initiates Coverage On Fortress Biotech with Buy Rating, Announces Price Target of $5
19 Mar 24
News, Price Target, Initiation, Analyst Ratings
Roth MKM Reinstates Buy on Fortress Biotech, Announces $10 Price Target
15 Mar 24
News, Price Target, Initiation, Analyst Ratings
Phase 1 CAR T Cell Therapy Trial For Glioblastoma At City Of Hope, Demonstrates Clinical Activity Against Incurable Brain Tumors, The IL13Rα2-Targeting CAR T Cell Is Exclusively Licensed By Mustang Bio, A Fortress Biotech Company
7 Mar 24
Biotech, News, Health Care, General
Press releases
Avenue Therapeutics Announces Reverse Stock Split
24 Apr 24
Press Releases
Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune Diseases
28 Mar 24
Health Care, Press Releases, General
Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024
25 Mar 24
News, Press Releases
Checkpoint Therapeutics Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
22 Mar 24
Earnings, Press Releases
Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
21 Mar 24
Earnings, Press Releases
Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights
18 Mar 24
Earnings, Press Releases
Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024
15 Mar 24
Press Releases
Avenue Therapeutics Receives Positive Listing Determination from Nasdaq
15 Mar 24
Press Releases
Journey Medical Corporation to Participate in the 36th Annual ROTH Conference
13 Mar 24
News, Press Releases
Fortress Biotech to Participate in 36th Annual ROTH Conference
12 Mar 24
News, Press Releases
Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting
11 Mar 24
Analyst Ratings, Press Releases
Avenue Therapeutics to Present BAER-101 Preclinical Data at American Society for Experimental Neurotherapeutics (ASENT) 2024 Annual Meeting
11 Mar 24
News, Analyst Ratings, Press Releases
Mustang Bio Announces Publication in Nature Medicine of Data from Phase 1 Trial Evaluating MB-101 IL13Rα2-targeted CAR T-Cells in High-Grade Glioma
7 Mar 24
Press Releases
City of Hope-developed Chimeric Antigen Receptor (CAR) T Cell Therapy Shows Clinical Activity in Patients With Aggressive Brain Tumors in a Phase 1 Trial
7 Mar 24
Press Releases
Fortress Biotech and Cyprium Therapeutics Announce $4.1 Million Grant from NINDS to Further Development of AAV-ATP7A Gene Therapy for Menkes Disease
4 Mar 24
News, Financing, Press Releases
Avenue Therapeutics Announces Publication in Drug Development Research Highlighting First-In-Class Preclinical Data of BAER-101 in a Translational Model of Absence Epilepsy
22 Feb 24
Press Releases
Lindsay Rosenwald's Fortress Bio (NASDAQ: FBIO) Spotlight on 2024 Milestones from Subsidiaries
2 Feb 24